Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003452 |
---|---|
Receipt number | R000004155 |
Scientific Title | Randomized contorol trial of transarterial chemoinfusion with cisplatin-lipiodol susupension or miriplatin-lipiodol suspension for advanced HCC |
Date of disclosure of the study information | 2010/05/01 |
Last modified on | 2021/10/13 18:31:24 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/04/05 17:41:16 | ||
2 | Update | 2010/04/07 18:34:21 | Key inclusion criteria Key inclusion criteria |
|
3 | Update | 2010/07/27 16:00:35 | Name of person sending information Organization Division name Address |
|
4 | Update | 2015/04/06 07:53:49 | TEL Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2016/10/11 08:11:32 | Name of primary person or sponsor Organization |
|
6 | Update | 2019/10/13 07:58:21 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
7 | Update | 2019/10/13 08:18:41 | Date of IRB Last follow-up date |
|
8 | Update | 2021/10/13 18:28:18 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
9 | Update | 2021/10/13 18:30:46 | Recruitment status |
|
10 | Update | 2021/10/13 18:31:24 | Publication of results |